Table 3.
Common ADC payloads
| Type of toxic payload | Payload | Representative tumor-targeting ADCs |
|---|---|---|
| Microtubule-targeting payload | Maytansinoids | PF-06647020 |
| Auristatin | IMGN901, MRG003, Teliso-V, BA3011 TIVDAK, Glembatumumab vedotin, Tisotumab vedotin, EnaV | |
| Eribulin | BB-1701 | |
| Tubulysins | EC1428 | |
| Cryptophycins | Dictyostatin | |
| EG5 inhibitors | – | |
| DNA-targeting payload | Enediyne | Loncastuximab tesirine-lpyl |
| Topoisomerase I inhibitors | DXd | |
| PBD | Zynlonta | |
| Duocarmycins | Trastuzumab duocarmazine | |
| RNA-targeting payload | Thailanstatin | MC-Thailanstatin A |
| Amatoxins | – | |
| Immune agonist | Toll-like receptor agonists | BDC-1001, Silverback |
| STING agonists | XMT-2056 | |
| Glucocorticoid receptor modulators | ABBV-319 |
ADC antibody drug conjugate, PBD pyrrolobenzodiazepines